ClinicalTrials.gg
CompletedNCT07916441HormonalUpdated Nov 4, 2026

PLISSIT Model Counseling on Sexual Function and Psychological Distress Among Hormonal Contraceptive Users

An interventional study of PLISSIT Model-Based Counseling in Female Sexual Dysfunction, sponsored by Al-Zaytoonah University of Jordan. Completed at 1 site in Jordan. Open to female participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Al-Zaytoonah University of Jordan · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 4 months after the study started (first participant enrolled Jun 2025, registered Oct 2026).
Updated Nov 4, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
187
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
Female
01

Study summary

Hormonal contraceptives are widely used by women to prevent pregnancy. However, some women experience sexual problems, such as reduced sexual desire, difficulty becoming sexually aroused, inadequate lubrication, difficulty reaching orgasm, or pain during sexual activity. These problems may negatively affect women's psychological well-being and quality of life.

This randomized controlled trial aimed to evaluate whether counseling based on the PLISSIT model could improve sexual function and reduce psychological distress among women experiencing sexual dysfunction while using hormonal contraceptives.

A total of 374 eligible women were randomly assigned to two groups. The intervention group received structured counseling based on the PLISSIT model, which includes four levels: Permission, Limited Information, Specific Suggestions, and Intensive Therapy. The counseling was delivered through five interactive group sessions. The control group received routine care without the structured PLISSIT counseling intervention.

Sexual function was assessed using the Female Sexual Function Index (FSFI), while psychological distress was assessed using the Kessler Psychological Distress Scale (K10). Both outcomes were measured before the intervention and four weeks after the intervention.

The study sought to determine whether PLISSIT-based counseling could improve women's sexual function and reduce psychological distress compared with routine care. The findings may help inform the development of nursing counseling interventions that address women's sexual health and psychological well-being.

Read the detailed description

This study was a parallel-group randomized controlled trial conducted among women attending two maternal and child health centers in Shibin El Kom, Menoufia Governorate, Egypt, between June and November 2025.

The study included 374 women who were using hormonal contraceptive methods and reported sexual dysfunction at baseline. Eligible participants were randomly allocated in a 1:1 ratio to either an intervention group or a control group.

The intervention group received structured counseling based on the PLISSIT model, a framework for addressing sexual health concerns through four progressive levels:

  1. Permission: Encouraging women to express their sexual concerns in a supportive and confidential environment.
  2. Limited Information: Providing relevant information about sexual health, hormonal contraception, and factors that may affect sexual function.
  3. Specific Suggestions: Offering individualized recommendations and practical strategies to address reported sexual difficulties.
  4. Intensive Therapy: Identifying women who may require further specialized assessment or referral.

The intervention was delivered through five interactive group counseling sessions, each lasting approximately one hour. The control group received routine maternal and child health services without the structured PLISSIT counseling program.

The primary outcome was sexual function, assessed using the Female Sexual Function Index (FSFI). The secondary outcome was psychological distress, assessed using the Kessler Psychological Distress Scale (K10).

Both outcomes were assessed at baseline and four weeks after the intervention. The study compared changes in sexual function and psychological distress between the intervention and control groups to evaluate the effectiveness of PLISSIT-based counseling.

The study was designed to assess whether structured, nurse-led psychosexual counseling could provide an effective approach to improving sexual health and psychological well-being among women using hormonal contraceptives.

02

Conditions studied

  • Female Sexual Dysfunction

Keywords

  • PLISSIT Counseling Sexual Function Sexual Dysfunction Hormonal Contraception
03

In context

Lead sponsor

Al-Zaytoonah University of Jordan is the lead sponsor of 31 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Women using hormonal methods.
  2. Women reporting sexual dysfunction at baseline, defined by an FSFI total score below 28.
  3. Women willing to participate in the study and provide .

Exclusion criteria

Exclusion Criteria:

  1. Women who were not using hormonal methods.
  2. Women without sexual dysfunction at baseline.
  3. Women with chronic physical or mental health conditions that could interfere with sexual function or participation in the counseling intervention.
  4. Women who participated in the pilot study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
187 participants (actual)

Study arms

  • No intervention
    Routine Care

    Participants received routine maternal and child health care services

  • Experimental
    PLISSIT Model Counseling

    Participants and care providers were not blinded to group allocation because of the nature of the counseling intervention. Outcome assessors and the statistical analyst were blinded to participants' group assignments.

    Behavioral: PLISSIT Model-Based Counseling

Interventions

  • BehavioralPLISSIT Model-Based Counseling

    A structured behavioral counseling intervention based on the PLISSIT model (Permission, Limited Information, Specific Suggestions, and Intensive Therapy). The intervention consisted of five interactive group counseling sessions, each lasting approximately one hour. Sessions addressed sexual health concerns among women using hormonal contraceptives, provided information about sexual function, and offered specific recommendations to manage reported sexual difficulties. The intervention aimed to improve sexual function and reduce psychological distress.

06

What researchers measure

Primary outcomes

  1. Change in Female Sexual Function Index (FSFI) Total Score

    Sexual function was assessed using the Female Sexual Function Index (FSFI), a 19-item questionnaire covering six domains: desire, arousal, lubrication, orgasm, satisfaction, and pain. The total score was used to evaluate changes in sexual function following PLISSIT model-based counseling. Higher total scores indicate better sexual function.

    Time frame: Baseline (before the intervention) and 4 weeks after the intervention.

07

Study locations

1 site
  • Al zaytoonah University
    Amman, 00000, Jordan
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jun 2025 to primary completion in Nov 2025, 5 months.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2026
First posted
Nov 4, 2026
StartActual
Jun 4, 2025
Primary completionActual
Nov 5, 2025
CompletionActual
Dec 7, 2025
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07916441
Lead sponsor
Al-Zaytoonah University of Jordan
Responsible party
Eman Abdelfatah Shokr (Menoufia University, Al-Zaytoonah University of Jordan) — Principal investigator
First posted
Nov 4, 2026
Start date
Jun 4, 2025
Primary completion
Nov 5, 2025
Completion
Dec 7, 2025
Last update
Nov 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion